DPC Holdings (DPC) director buys IPO shares and receives option grants
Rhea-AI Filing Summary
DPC Holdings Ltd director Willibald Meixner increased his stake and received new equity awards. On June 26, 2026, he purchased 3,784 ordinary shares in the open market at $33 per share through a directed share program tied to the company’s initial public offering.
He also received a fully vested matching grant of 946 ordinary shares under the DPC Holdings Limited 2026 Equity Incentive Plan, and on June 24, 2026 was granted several tranches of share options covering ordinary shares with exercise prices between $33.00 and $48.31, exercisable from 2027 to 2031 and expiring in 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 4,730 shares
Net Buy
7 txns
Insider
Meixner Willibald
Role
Director
Bought
3,784 shs ($125K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Ordinary Shares | 3,784 | $33.00 | $125K |
| Grant/Award | Ordinary Shares | 946 | $0.00 | $0.00 |
| Grant/Award | Share Options (right to buy) | 20,829 | $0.00 | $0.00 |
| Grant/Award | Share Options (right to buy) | 20,829 | $0.00 | $0.00 |
| Grant/Award | Share Options (right to buy) | 20,829 | $0.00 | $0.00 |
| Grant/Award | Share Options (right to buy) | 20,829 | $0.00 | $0.00 |
| Grant/Award | Share Options (right to buy) | 20,830 | $0.00 | $0.00 |
Holdings After Transaction:
Share Options (right to buy) — 104,146 shares (Direct);
Ordinary Shares — 4,730 shares (Direct)
Footnotes (3)
- F1. Reflects ordinary shares acquired through a directed share program conducted in connection with the Issuer's initial public offering and consists of shares purchased under the Director Share Program pursuant to the DPC Holdings Limited 2026 Equity Incentive Plan (the "Equity Incentive Plan").
- F2. Reflects fully vested ordinary shares granted pursuant to the Equity Incentive Planas as a matching grant related to shares purchased under the Director Share Program as described in footnote 1.
- F3. Reflects share options granted pursuant to the Equity Incentive Plan in connection with the closing of the Issuer's initial public offering (the "IPO Grants").
Key Figures
Open-market purchase: 3,784 shares at $33.00
Matching share grant: 946 ordinary shares
Option grant tranche 1: 20,830 options at $48.31
+4 more
7 metrics
Open-market purchase
3,784 shares at $33.00
Ordinary shares bought on June 26, 2026
Matching share grant
946 ordinary shares
Fully vested grant under 2026 Equity Incentive Plan
Option grant tranche 1
20,830 options at $48.31
Share options granted June 24, 2026, expiring 2036
Option grant tranche 2
20,829 options at $43.92
Share options granted June 24, 2026, expiring 2036
Option grant tranche 3
20,829 options at $39.93
Share options granted June 24, 2026, expiring 2036
Option grant tranche 4
20,829 options at $36.30
Share options granted June 24, 2026, expiring 2036
Option grant tranche 5
20,829 options at $33.00
Share options granted June 24, 2026, expiring 2036
Key Terms
directed share program, Director Share Program, DPC Holdings Limited 2026 Equity Incentive Plan, IPO Grants
4 terms
DPC Holdings Limited 2026 Equity Incentive Plan financial
"purchased under the Director Share Program pursuant to the DPC Holdings Limited 2026 Equity Incentive Plan"
IPO Grants financial
"Reflects share options granted pursuant to the Equity Incentive Plan in connection with the closing of the Issuer's initial public offering (the "IPO Grants")"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did DPC (DPC) director Willibald Meixner report?
Director Willibald Meixner reported buying 3,784 ordinary DPC shares at $33 per share and receiving 946 fully vested matching shares. He also received several option grants over ordinary shares under the company’s 2026 Equity Incentive Plan.
What stock options were granted to the DPC (DPC) director in this filing?
He was granted multiple tranches of share options over DPC ordinary shares, including 20,830 options at a $48.31 exercise price and several 20,829-option tranches at lower exercise prices, all expiring in 2036 and classified as IPO-related grants.